 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 1999, 19(10):3952-3961
Contributions of the Brain Angiotensin IV-AT4 Receptor
Subtype System to Spatial Learning
John W.
Wright1, 2, 3,
LeighAnn
Stubley4,
Eric S.
Pederson3,
Enikö A.
Kramár3,
Jodi M.
Hanesworth2, and
Joseph W.
Harding1, 2, 3
Departments of 1 Psychology,
2 Veterinary and Comparative Anatomy, Pharmacology, and
Physiology, and 3 Program in Neuroscience, Washington State
University, Pullman, Washington 99164, and 4 Center for
Neurobiology of Aging, University of Florida, Gainesville, Florida
32610
The development of navigational strategies to solve spatial
problems appears to be dependent on an intact hippocampal formation. The circular water maze task requires the animal to use extramaze spatial cues to locate a pedestal positioned just below the surface of
the water. Presently, we investigated the role of a recently discovered
brain angiotensin receptor subtype (AT4) in the
acquisition of this spatial learning task. The AT4 receptor
subtype is activated by angiotensin IV (AngIV) rather than angiotensins
II or III, as documented for the AT1 and AT2
receptor subtypes, and is heavily distributed in the
CA1-CA3 fields of the hippocampus. Chronic intracerebroventricular infusion of a newly synthesized
AT4 agonist (Norleucine1-AngIV) via
osmotic pump facilitated the rate of acquisition to solve this
task, whereas treatment with an AT4 receptor antagonist (Divalinal) significantly interfered with the acquisition of successful search strategies. Animals prepared with bilateral knife cuts of the
perforant path, a major afferent hippocampal fiber bundle originating
in the entorhinal cortex, displayed deficits in solving this task. This
performance deficit could be reversed with acute intracerebroventricular infusion of a second AT4 receptor
agonist (Norleucinal). These results suggest that the brain
AngIV-AT4 system plays a role in the formation of spatial
search strategies and memories. Further, application of an
AT4 receptor agonist compensated for spatial memory
deficits in performance accompanying perforant path knife cuts.
Possible mechanisms underlying this compensatory effect are discussed.
Key words:
spatial memory; hippocampus; perforant path knife cuts; angiotensin IV analogs; AT4 receptor; circular water
maze
Copyright © 1999 Society for Neuroscience 0270-6474/99/19103952-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. W Wright and J. W Harding
The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease
Journal of Renin-Angiotensin-Aldosterone System,
December 1, 2008;
9(4):
226 - 237.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Albiston, C. J. Morton, H. L. Ng, V. Pham, H. R. Yeatman, S. Ye, R. N. Fernando, D. De Bundel, D. B. Ascher, F. A. O. Mendelsohn, et al.
Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase
FASEB J,
December 1, 2008;
22(12):
4209 - 4217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. McKinley, L. L. Walker, T. Alexiou, A. M. Allen, D. J. Campbell, R. Di Nicolantonio, B. J. Oldfield, and D. A. Denton
Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2008;
294(5):
R1533 - R1543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev,
July 1, 2006;
86(3):
747 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lochard, G. Thibault, D. W. Silversides, R. M. Touyz, and T. L. Reudelhuber
Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist
Circ. Res.,
June 11, 2004;
94(11):
1451 - 1457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G Kehoe
Review: The renin-angiotensin-aldosterone system and Alzheimer's disease?
Journal of Renin-Angiotensin-Aldosterone System,
June 1, 2003;
4(2):
80 - 93.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai
Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
205 - 211.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
Journal of Renin-Angiotensin-Aldosterone System,
December 1, 2002;
3(4):
195 - 204.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hu, A. Igarashi, M. Kamata, and H. Nakagawa
Angiotensin-converting Enzyme Degrades Alzheimer Amyloid beta -Peptide (Abeta ); Retards Abeta Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity
J. Biol. Chem.,
December 14, 2001;
276(51):
47863 - 47868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn
Bioactive angiotensin peptides: focus on angiotensin IV
Journal of Renin-Angiotensin-Aldosterone System,
December 1, 2001;
2(4):
205 - 210.
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Albiston, S. G. McDowall, D. Matsacos, P. Sim, E. Clune, T. Mustafa, J. Lee, F. A. O. Mendelsohn, R. J. Simpson, L. M. Connolly, et al.
Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
J. Biol. Chem.,
December 21, 2001;
276(52):
48623 - 48626.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|